Trexquant Investment LP Takes $385,000 Position in Phibro Animal Health Corporation $PAHC

Trexquant Investment LP bought a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 18,032 shares of the company's stock, valued at approximately $385,000.

A number of other large investors have also modified their holdings of PAHC. Man Group plc acquired a new position in shares of Phibro Animal Health during the 4th quarter valued at about $501,000. GAMMA Investing LLC lifted its position in Phibro Animal Health by 2,011.4% in the first quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock valued at $784,000 after buying an additional 34,979 shares during the last quarter. LPL Financial LLC lifted its position in Phibro Animal Health by 46.8% in the first quarter. LPL Financial LLC now owns 128,335 shares of the company's stock valued at $2,741,000 after buying an additional 40,889 shares during the last quarter. Lazard Asset Management LLC lifted its position in Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after buying an additional 1,589 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its position in Phibro Animal Health by 21.4% in the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after buying an additional 103,618 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of recent research reports. Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a research note on Thursday, August 28th. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Bank of America boosted their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an "underperform" rating in a research note on Friday, August 29th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their target price for the stock from $25.00 to $35.00 in a research note on Monday, July 7th. Finally, Zacks Research lowered shares of Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 28th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average target price of $28.40.

Phibro Animal Health Trading Down 3.8%

PAHC traded down $1.57 during midday trading on Friday, hitting $39.62. The company's stock had a trading volume of 238,815 shares, compared to its average volume of 389,217. The company has a current ratio of 2.76, a quick ratio of 1.25 and a debt-to-equity ratio of 2.46. The firm has a market cap of $1.61 billion, a P/E ratio of 33.58, a PEG ratio of 1.22 and a beta of 0.89. The firm has a 50-day moving average price of $31.98 and a two-hundred day moving average price of $25.53. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $41.57.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.52 by $0.05. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The firm had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, research analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio is presently 40.68%.

Insider Activity

In other news, CEO Jack Bendheim sold 14,080 shares of the stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $40.33, for a total value of $567,846.40. Following the completion of the transaction, the chief executive officer owned 45,400 shares of the company's stock, valued at approximately $1,830,982. This represents a 23.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 50.07% of the company's stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.